FOXA1 Regulation Turns Benzamide HDACi Treatment Effect-Specific in BC, Promoting NIS Gene-Mediated Targeted Radioiodine Therapy

MLA

Girish Salve, et al. “FOXA1 Regulation Turns Benzamide HDACi Treatment Effect-Specific in BC, Promoting NIS Gene-Mediated Targeted Radioiodine Therapy.” Molecular Therapy - Oncolytics, vol. 19, Dec. 2020, pp. 93–104. EBSCOhost, https://doi.org/10.1016/j.omto.2020.08.015.

APA

Girish Salve, Abhijit De, Madhura Kelkar, Maitreyi Rathod, & Snehal K. Valvi. (2020). FOXA1 Regulation Turns Benzamide HDACi Treatment Effect-Specific in BC, Promoting NIS Gene-Mediated Targeted Radioiodine Therapy. Molecular Therapy - Oncolytics, 19, 93–104. https://doi.org/10.1016/j.omto.2020.08.015

Chicago

Girish Salve, Abhijit De, Madhura Kelkar, Maitreyi Rathod, and Snehal K. Valvi. 2020. “FOXA1 Regulation Turns Benzamide HDACi Treatment Effect-Specific in BC, Promoting NIS Gene-Mediated Targeted Radioiodine Therapy.” Molecular Therapy - Oncolytics 19 (December): 93–104. doi:10.1016/j.omto.2020.08.015.